Effectiveness of a recent topical sialogogue in the management of drug-induced xerostomia.

Journal of Clinical and Experimental Dentistry

Volumn 3, Issue 4, 2011, Pages 268-273

  Martin Piedra M A ^a   Aguilar Salvatierra, A ^a   Herrera, D ^b   Gomez Moreno G ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Antidepressant agents; Antihypertensive agents; Malic acid; Xerostomia

Indexed keywords

EID: 84865187073     PISSN: None     EISSN: 19895488     Source Type: Journal    
DOI: 10.4317/jced.3.e268     Document Type: Article

References (29)

1. Leung KC, McMillan AS, Wong MC, Leung WK, Mok MY, Lau CS. The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjogren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study. Clin Rheumatol. 2008;27: 429-36.
2. Almståhl A, Wikstrom M. Microflora in oral ecosystems in subjects with hyposalivation due to medicines or of unknown origin. Oral Health Prev Dent. 2005;3: 67-76.
3. Markitziu A, Zafiropoulos G, Tsalikis L, Cohen L. Gingival health and salivary function in head and neck-irradiated patients. A five-year follow-up. Oral Surg Oral Med Oral Pathol. 1992;73: 427-33.
4. Daniels TE, Wu AJ. Xerostomia--clinical evaluation and treatment in general practice. J Calif Dent Assoc. 2000;28: 933-41.
5. Scully C, Bagan JV. Adverse drug reactions in the orofacial region. Crit Rev Oral Biol Med. 2004;15: 221-39.
6. Murray Thomson W, Chalmers JM, John Spencer A, Slade GD, Carter KD. A longitudinal study of medication exposure and xerostomia among older people. Gerodontology. 2006;23: 205-13.
7. de Almeida PdV, Gregio AM, Brancher JA, Ignacio SA, Machado MA, de Lima AA, et al. Effects of antidepressants and benzodiazepines on stimulated salivary flow rate and biochemistry composition of the saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106: 58-65.
8. Nederfors T. Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists. Swed Dent J Suppl. 1996;116: 1-70.
9. Mangrella M, Motola G, Russo F, Mazzeo F, Giassa T, Falcone G, et al. [Hospital intensive monitoring of adverse reactions of ACE inhibitors]. Minerva Med. 1998;89: 91-7.
10. Strietzel FP, Martin-Granizo R, Fedele S, Lo Russo L, Mignogna M, Reichart PA, et al. Electrostimulating device in the management of xerostomia. Oral Dis. 2007;13: 206-13.
11. Blom M, Lundeberg T. Long-term follow-up of patients treated with acupuncture for xerostomia and the influence of additional treatment. Oral Dis. 2000;6: 15-24.
12. Cassolato SF, Turnbull RS. Xerostomia: clinical aspects and treatment. Gerodontology. 2003;20: 64-77.
13. Murray Thomson W, Poulton R, Mark Broadbent J, Al-Kubaisy S. Xerostomia and medications among 32-year-olds. Acta Odontol Scand. 2006;64: 249-54.
14. Thomson WM, Chalmers JM, Spencer AJ, Williams SM. The Xerostomia Inventory: a multi-item approach to measuring dry mouth. Community Dent Health. 1999;16: 12-7.
15. Garcia MK, Chiang JS, Cohen L, Liu M, Palmer JL, Rosenthal DI, et al. Acupuncture for radiation-induced xerostomia in patients with cancer: a pilot study. Head Neck. 2009;31: 1360-8.
16. Thomson WM, Williams SM. Further testing of the xerostomia inventory. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89: 46-50.
17. Navazesh M, Christensen CM. A comparison of whole mouth resting and stimulated salivary measurement procedures. J Dent Res. 1982;61: 1158-62.
18. McMillan AS, Tsang CS, Wong MC, Kam AY. Efficacy of a novel lubricating system in the management of radiotherapy-related xerostomia. Oral Oncol. 2006;42: 842-8.
19. Sreebny L. Saliva-salivary gland hypofunction (SGH). FDI Working Group 10. J Dent Assoc S Afr. 1992;47: 498-501.
20. Gambon DL, Brand HS, Nieuw Amerongen AV. The erosive potential of candy sprays. Br Dent J. 2009;206: E20; discussion 530-1.
21. Anneroth G, Nordenram G, Bengtsson S. Effect of saliva stimulants (Hybrin and malic acid) on cervical root surfaces in vitro. Scand J Dent Res. 1980;88: 214-8.
22. Chunmuang S, Jitpukdeebodintra S, Chuenarrom C, Benjakul P. Effect of xylitol and fluoride on enamel erosion in vitro. J Oral Sci. 2007;49: 293-7.
23. Hove LH, Holme B, Young A, Tveit AB. The protective effect of TiF4, SnF2 and NaF against erosion-like lesions in situ. Caries Res. 2008;42: 68-72.
24. da Mata AD, da Silva Marques DN, Silveira JM, Marques JR, de Melo Campos Felino ET, Guilherme NF. Effects of gustatory stimulants of salivary secretion on salivary pH and flow: a randomized controlled trial. Oral Dis. 2009;15: 220-8.
25. Fox PC. Salivary enhancement therapies. Caries Res. 2004;38: 241-6.
26. Vissink A, Burlage FR, Spijkervet FK, Jansma J, Coppes RP. Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14: 213-25.
27. Cho JH, Chung WK, Kang W, Choi SM, Cho CK, Son CG. Manual acupuncture improved quality of life in cancer patients with radiation-induced xerostomia. J Altern Complement Med. 2008;14: 523-6.
28. Pfister DG, Cassileth BR, Deng GE, Yeung KS, Lee JS, Garrity D, et al. Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. J Clin Oncol. 2010;28: 2565-70.
29. Thomson WM. Measuring change in dry-mouth symptoms over time using the Xerostomia Inventory. Gerodontology. 2007;24: 30-5.